Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy
NCT06328725
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
88
Enrollment
INDUSTRY
Sponsor class
Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG:
EN001
Sponsor
ENCell